Bloomage Biotech

Forecast & Rating9 analysts currently cover Bloomage Biotech, with about 33.3% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥35.70, about 4.6% upside from the current price of ¥34.14. Price targets range from ¥23.00 to ¥52.20 — a wide spread, showing clear disagreement over just how much Bloomage Biotech can rise. Historically, about 36.8% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Bloomage Biotech's outlook. Data as of Sep 16, 2026; for reference only and not investment advice.